Summary: The objective of this study was to identify the nitrogen oxide form(s) involved in the functional impairment of the rat taurine transport system. Taurine uptake activity in the rat renal brush border membrane vesicle (RBBMV) preparation or Xenopus laevis oocytes that express the rat taurine transporter was compared after the pretreatment with nitrogen oxide donors from which nitric oxide (NO) is released at different rates. The functional impairment was associated with a reduced V max , but did not involve an alteration in the K m , of taurine uptake in the RBBMV preparation that had been pretreated with sodium nitroprusside, a slow release nitric oxide (NO) donor. When the preparation was pretreated with S-nitroso-N-acetyl penicillamine, a rapid release NO donor, the activity of taurine uptake was unaffected. The activity was not statistically different from the control after the pretreatment with sodium nitroprusside and superoxide dismutase. Consistent with the study with RBBMV, a similar alteration in the activity of taurine uptake by NO donors was observed in oocytes expressing the transporter. Considering the fact that peroxynitrite, a highly reactive nitrogen oxide form, is formed by the reaction between NO and superoxide, the taurine transporter, and probably other transport systems as well, may be functionally impaired by peroxynitrite.
Introduction
Taurine represents one of the most abundant intracellular free amino acids. 1¥ Although its physiological role has not been fully delineated, taurine appears to be crucial in the development of the brain for certain mammals. 2¥ The homeostasis of intracellular taurine appears to be partly maintained by the salvage mechanism via a transporter expressed in the plasma membrane of mammalian cells. Indeed, it has been indicated that a Na ¦ -dependent secondary active transport system exists for taurine in the apical membrane of the renal 3¥ and choroid plexus epithelia 4¥ in rats. A considerable body of literature evidence exists for the modification and functional alteration of proteins by nitrogen oxides ¤NOs¥.
5®7¥ In addition, a functional impairment has been reported for glutamate, serotonin, and folate transport in the presence of NOs. 8®10¥ In our previous study, the functional activities of secondary active transport systems, including the taurine uptake system, at the barrier between the systemic circulation and the cerebrospinal fluid ¤CSF¥ were reduced after an induction of the inflammation in the CSF, and the functional impairment reversed by pretreatment with an NO synthase inhibitor. 11¥ In addition, in vitro taurine uptake activity was reduced in the choroid plexus ¤i.e., the blood-CSF barrier¥ by the pre-treatment with sodium nitroprusside ¤SN¥, suggesting that the taurine uptake is functionally sensitive to NOs. Interestingly, however, Smith 10¥ found that the pre-treatment of Snitroso-N-acetylpenicillamine ¤SNAP¥ had no effect on the taurine uptake in human retinal pigment epithelial cells. The underlying mechanism for such a discrepancy by NO donors has not been elucidated. Considering the remarkable similarity between rat vs. human taurine transporters ¤viz, 90.3% homology in nucleotide sequence¥, the species difference is not likely to be the primary mechanism. Since SN and SNAP release NO differently, 12, 13¥ the discrepancy in the sensitivity may arise from the difference in NO release rate. Consistent with this observation, it has been reported that a rapidly releasing NO donor, such as SNAP, is not likely to form peroxynitrite, a potent oxidant, effectively in a biological system. 10¥ For NO donors such as SNAP, the efficient generation of NO may be preferentially reacted with oxygen to form inorganic nitrite, a relatively nonreactive NO form, rather than reacted with superoxide to form peroxynitrite. Despite the possibility, however, this aspect of functional impairment has not been studied for taurine transporters. In addition, other transport systems are functionally affected by nitrogen oxide forms, yet the underlying mechanism¤s¥ for the functional impairment has not been fully elucidated.
The objective of the study is to examine the effect of NO donors with different releasing rates on the functional activity of taurine transport in the rat renal brush border membrane vesicle ¤RBBMV¥ preparation and Xenopus laevis oocytes expressing transporter. Preparation of rat RBBMVs: Rat RBBMVs were prepared by the Ca 2¦ -precipitation method according to the procedure described by Kessler et al. 14¥ Briefly, five Sprague-Dawley rats ¤body weight 280®350 g¥ were sacrificed by cervical dislocation and the kidneys collected. The cortex of the kidneys was dissected with surgical scissors and collected in a 100 ml beaker containing ice cold buffer A ¤10 mM mannitol, 2 mM HEPES-Tris, pH 7.5¥. The RBBMV preparation was carried out either on ice or in a chamber maintained at 4ôC. The cortex was minced thoroughly and homogenized with a loose fitting Dounce homogenizer with nine times the volume of the tissue, assuming the density to be the same. The homogenate was filtered through two layers of gauze and CaCl 2 solution added to the filtrate to obtain a final CaCl 2 concentration of 10 mM. The resulting mixture was held at room temperature for 15 min and a crude vesicle preparation collected by a sequential centrifugation ¤750 ' g spin for 12 min, supernatant, followed by 15,000 ' g spin for 12 min, pellet¥. The crude fraction was re-suspended and homogenized again in CaCl 2 solution ¤final concentration of CaCl 2 , 10 mM¥. The mixture was placed on ice for 15 min and subjected to a sequential centrifugation ¤750 ' g spin for 12 min, supernatant, followed by 30,000 ' g spin for 12 min, pellet¥. The resulting pellet was re-suspended in ice-cold buffer B ¤100 mM mannitol, 20 mM HEPES-Tris pH 7.5¥ and the resuspension centrifuged at 48,000 ' g for 20 min. The pellet was subjected to re-suspension and low speed spin ¤2,000 ' g for 12 min¥ for washing. The supernatant was then centrifuged at 48,000 ' g for 20 min and the pellet resuspended in ice-cold revesicularization medium ¤120 mM KCl, 60 mM mannitol, 20 mM HEPES-Tris, pH 7.5¥. The preparation was aliquoted out ¤1 ml each¥ and stored at %70ôC.
Meterials and Methods

Materials
Characterization and confirmation of transport function in the rat RBBMV preparation:
The concentration of total protein in the Rat RBBMV was measured by Lowry assay 15¥ using bovine serum albumin as a standard. The activity of the marker enzyme was determined by alkaline phosphatase activity assay.
16¥
To confirm the functional activity of transport system in the RBBMV preparation, the glucose uptake into the RBBMV was compared in the presence and the absence of Na ¦ -gradient. Ice-cold stop solution ¤100 ml mannitol, 20 mM Tris-HEPES, 100 mM NaCl, 1 mM glucose¥, incubation solution ¤120 mM NaCl, 60 mM mannitol, 20 mM Tris-HEPES¥, and revesicularization medium ¤120 mM KCl, 60 mM mannitol, 20 mM Tris-HEPES¥ were prepared and the pH adjusted to 7.5. To examine the effect of no Na ¦ -gradient, NaCl was replaced with KCl for ice-cold stop solution and incubation solution. The solutions were then filtered with a membrane filter ¤0.2 µm pore size, Advantec Inc., Pleasanton, CA¥, prior to the transport study. The filter membrane was pre-soaked in ice-cold stop solution for 2 h. An aliquot ¤10 µl¥ of the rat RBBMV preparation was added to incubation tubes and pre-incubated for 2 min at 37ôC. The transport was initiated by the addition of 50 µl of pre-warmed incubation medium containing glucose ¤the final concentrations, unlabelled glucose, 10 µM; ª 3 H«glucose, 1.7 µM¥. At various times, the uptake reaction was terminated by the addition of ice-cold stop solution ¤1 ml¥ to the incubation, and the mixture was rapidly filtered under vacuum using a pre-soaked filter membrane ¤0.2 µm pore size¥. The membrane filter was washed twice with ice cold stop solution ¤1 ml for the first wash; 5 ml for the second wash¥, carefully removed from the rapid vacuum filtration set-up and added to a liquid scintillation vial. The scintillation medium ¤Ultima Gold, Pakard, Mediren, CT¥ was added to the vial and the mixture vortexed. The total radioactivity was counted in a Wallac 1409 liquid scintillation counter ¤PerkinElmer Life Sciences, Turku, Finland¥ after an overnight storage. The counting efficiency for ª 3 H«ranged from 35 to 45%. Transport of taurine in the rat RBBMV preparation: To study the Na ¦ -dependent taurine uptake in the rat RBBMV preparation, the temporal profile of taurine accumulation was studied in the presence and absence of Na ¦ -gradient. A transport study was carried out similarly to the glucose transport study except that the pre-warmed incubation medium contained radiolabelled and unlabelled taurine ¤the final concentration: unlabelled taurine, 3.4 µM, ª 3 H«taurine, 0.8 µM¥. The transport was monitored at 10, 20, 30, 60, 120, 300 and 3,600 s after the initiation of the study. The extent of uptake was assessed similarly to the procedure described in the glucose transport study. Na ¦ -dependent taurine uptake in the RBBMV in the presence and absence of SN: Previously, we demonstrated that pretreatment with SN led to a functional impairment of Na ¦ -dependent taurine uptake in the choroid plexus. To examine the functional impairment of the taurine uptake system by SN, the RBBMV was pre-treated with SN. A solution containing SN ¤1 mM, final concentration¥ and L-ascorbic acid ¤0.4 mM, final concentration¥ was added to the vesicle preparation. In the control group, a solution containing L-ascorbic acid only was added to the preparation. The mixture was incubated at 37ôC for 20 min, transferred to centrifugation tubes and revesicularization medium ¤28 ml¥ added. The resulting mixture was vortexed for 30 s and subjected to a centrifugation at 48,000 ' g for 15 min. The resulting pellet was resuspended in revesicularization medium with a 26G needle ¤Korea Vaccine Co., Seoul, Korea¥ to obtain a RBBMV preparation having a protein concentration of 40 µg/10 µl. An aliquot ¤10 µl¥ of the preparation was added to incubation tubes and pre-incubated for 2 min at 37ôC. The transport was initiated by the addition of 50 µl of pre-warmed incubation medium containing taurine ¤the final concentrations: unlabelled taurine, 0®80 µM; ª 3 H«taurine, 0.8 µM¥ and terminated after 20 s. The uptake mixture was processed similarly to the procedure described in the previous section. The rate of taurine uptake, in pmol/mg protein/20 s, was then calculated.
Transport of taurine after the pre-treatment with NO donors in the rat RBBMV: To study whether the functional activity of taurine uptake was affected differently by NO donors having different rates of NO release, the transport was compared between SN and SNAP pre-treated RBBMV preparation. A solution containing various components ¤viz, SN 1 mM, SOD 500 unit/ml or SNAP 1 mM in the final concentrations¥ along with L-ascorbic acid ¤0.4 mM, final concentration¥ was added to the vesicle preparation. In this study, the control incubation mixture contained Lascorbic acid ¤0.4 mM, final concentration¥ only. Pretreatment conditions ¤i.e., the duration of pretreatment and washing procedure¥ were described in the previous section. The transport was initiated by the addition of 50 µl of prewarmed incubation medium containing taurine ¤in the final concentrations: unlabelled taurine, 7.4 µM; ª 3 H«taurine, 0.8 µM¥ to the pretreated RBBMV and terminated after 20 s. The rate of taurine uptake, in pmol/mg protein/20 s, was then calculated.
Cloning of the rat taurine transporter ¤TauT¥: Rat kidney total RNA was isolated using RNA zol TM reagent. The cDNAs were synthesized with oligo ¤dT¥ 25 primer using the First Strand cDNA synthesis kit ¤MBI fermentas, Vilnius, Lithuania¥ and were used for PCR ¤Primus, Ebersberg, Germany¥. The primers for PCR were designed from the reference cDNA sequence for TauT ¤GenBank accession number: M96601¥. The selected primers were custom-synthesized and purified from Takara. Restriction sequences were added at the forward primer ¤EcoRI: 5$-CCCGAATTCGCCGCCACCATGGCCACC-AAGGAGAAGCTT-3$¥ and the reverse primer ¤XbaI: 5$-CCGTCTAGACATCATGGTCTCCACAATGAT-3$¥ to prepare cohesive ends after digestion with the restriction endonucleases. Thirty PCR heating cycles ¤i.e., 94ôC for 30 s, 57ôC for 1 min and 72ôC for 30 s¥ were carried out in this study. The purified PCR product was introduced to the pcDNA3.1 vector under the control of the T7 promoter. The resulting ligation product was transformed into E. coli DH5AE competent cells using a heat shock technique. The sequence was confirmed by DNA sequencing.
Expression in Xenopus laevis oocytes: The synthesis of capped cRNA was carried out using a MEGAscript T7 kit and 7-methyl guanosine cap analogue ¤m7G¤5$¥ppp¤5$¥G¥ ¤Ambion, Austin, TX¥. cDNAs were linearized by ScaI digestion and transcribed in vitro with T7 polymerase. Defolliculated, healthy stage V and VI oocytes were injected with 50 nl capped cRNAs ¤concentration: 1 µg/µl¥. If necessary, an equal volume of water was injected as a control. The injection was carried out under a dissecting microscope using a Nanoject II oocyte injector ¤Drummond Scientific Co., Broomall, PA¥. Injected oocytes were maintained in ND96 buffer ¤i.e., 96 mM NaCl, 2.0 mM KCl, 1.0 mM MgCl 2 , 5.0 mM HEPES and 2.5 mM sodium pyruvate and 50 µg/ml gentamycin¥ containing 5% horse serum.
Uptake of taurine in oocytes: Six days after the injection, groups of eight to ten oocytes were incubated at 25ôC for 1 h in 150 µl ND96 buffer containing radiolabelled taurine ¤i.e., ª 3 H«taurine 0.33 µM, cold taurine 5 µM¥. Water-injected oocytes were used as a control for nonspecific uptake of taurine. To examine the effect of the nitrogen oxide donor, the oocytes were pre-treated with 1 mM SN or SNAP for 20 min. When necessary, superoxide dismutase ¤SOD, 500 unit/ml¥ was added along with SN. Upon the termination of pre-treatment, the medium was aspirated out, and the oocytes washed with 3 ml of ND96 buffer 5 times. After replenishing the medium with ND96 buffer, taurine uptake ¤at substrate concentration 5.33 µM; ª 3 H«taurine 0.33 µM, cold taurine 5 µM¥ was then determined at 25ôC for 1 h. In this study, ª
14
C«mannitol was added as a passive diffusion marker. The uptake was terminated by the aspiration of the incubation medium and the oocytes were subsequently washed 5 times with 1 ml of fresh ice-cold ND96 buffer. The oocytes, then, were solubilized using 10% sodium dodecyl sulfate, and the radioactivity associated with oocytes counted by liquid scintillation counting.
Data analysis: To estimate kinetic parameters, initial uptake rates of taurine were plotted against the initial concentration in the medium, and the profile fitted to Eq. 1 using WinNonlin ¤version 3.1, Pharsight Co., Mountain View, CA¥;
where Ù 0 is the initial uptake rate ¤expressed as pmol/mg protein/20 s¥, and S represents the initial concentration of taurine in the medium. V max , K m and CL linear represent the maximum uptake rate, the medium concentration at half of maximal uptake rate and linear transport clearance, respectively. All data are expressed as mean + SD. To compare mean values between the pretreatments, Studentös t-test was used. In all cases, pg0.05 was accepted as denoting a significant difference.
Results
Characterization and confirmation of transport function in the rat RBBMV preparations: Alkaline phosphatase is an appropriate marker enzyme for assessing the integrity of brush border membrane vesicle preparation. 17¥ Typically, over eight-fold enrichment of the activity in vesicles, compared with that in the homogenate, has been regarded as a RBBMV preparation having an acceptable enrichment. 18®20¥ In this study, the alkaline phosphatase activity was 12.9 + 1.88 mmol/mg/h for the homogenate and 119.6 + 16.2 mmol/mg/h for RBBMV, an enhancement of the activity of 9.38 + 0.87 fold, indicating that the RBBMV preparation had an adequate enrichment.
To examine whether the RBBMV preparation is suitable for studying transport processes, Na ¦ -dependent D-glucose transport was determined. D-Glucose transporter has been shown to be responsible for the reabsorption of D-glucose in the kidney epithelial cells, and the glucose transporter function has been extensively studied in a number of renal brush border membrane vesicle preparations ¤Beck and Sacktor 21¥ ¥. D-Glucose accumulation in RBBMV in the presence of Na ¦ -gradient was markedly enhanced up to 1 min. As a result, úovershootû of the transport was readily apparent at 30®60 s after the addition of glucose ¤e.g., 2.3 + 1.0 without Na ¦ -gradient vs. 13.6 + 4.7 with Na ¦ -gradient, pg0.05¥. The accumulation was not statistically different at 2 min, indicating that an equilibrium was established within 2 min ¤data not shown¥. Taken together, the functional activities of the RBBMV preparation appeared adequate for subsequent studies. Na ¦ -dependent taurine uptake in the RBBMV preparation:
To examine whether RBBMV has a functional activity of Na ¦ -dependent taurine uptake system, the taurine uptake was compared in the presence and absence of 120 mM Na ¦ -gradient ¤Fig. 1¥. The accumulation of taurine in RBBMV reached a peak at approximately 1 min and was approximately 5-fold higher in the presence of Na ¦ -gradient than that in the absence of Na ¦ gradient ¤i.e., 8.1 + 0.8 with Na ¦ gradient vs. 1.6 + 0.2 without Na ¦ -gradient, pg0.01¥. The taurine accumulation in the RBBMV preparation with Na ¦ -gradient was significantly enhanced compared to that in the absence of Na ¦ -gradient up to 2 min ¤pg0.05¥. However, the difference disappeared beyond 5 min, indicating that an equilibrium was established within 5 min. Consistent with other literature evidence, 3¥ this observation indicated that a Na ¦ -dependent taurine transport system was functional in the rat RBBMV.
The concentration dependency of Na ¦ -dependent taurine uptake was compared with or without SN pretreatment ¤Fig. 2¥. At all concentration levels studied, the taurine uptake was reduced when RBBMV was pre-treated with SN, indicating that the pretreatment resulted in an impaired function of Na ¦ -dependent taurine transport. This observation was consistent with our previous results with ATPdepleted choroid plexus.
11¥ Eadie-Hofstee transformation analysis revealed that Na ¦ -dependent taurine uptake may be described by a mixed kinetic model involving both simple Michaelis-Menten and linear kinetics ¤data not shown¥. The results of kinetic analysis are summarized in Table 1 . K m and linear uptake clearance were not affected by the SN pretreatment ¤e.g., K m , 5.89 + 1.57 µM and 3.68 + 2.45 µM for control RBBMV and SN pretreated RBBMV, respectively; CL linear , 0.0966 + 0.0273 µl/mg protein/ 20 s and 0.0734 + 0.0098 µl/mg protein/20 s for con- Functional Impairment of Rat Taurine Transporter by NO xtrol RBBMV and SN pretreated RBBMV, respectively¥. In contrast, V max was significantly reduced ¤61.4% reduction from the control; for control RBBMV, 5.14 + 0.96 pmol/ mg protein/20 s; for SN pretreated RBBMV, 1.98 + 0.60 pmol/mg protein/20 s; pg0.05¥. Since V max is a measure of total number of functional transporter, the significant decrease may suggest that SN pretreatment reduced the number of functional Na ¦ -dependent taurine uptake system in the RBBMV. Subsequent studies were conducted to determine the activity of the taurine uptake system in the presence of NO donors with different release rates.
Functional impairment of taurine uptake by NO donors: After RBBMV was pretreated with SN ¤i.e., a slow-release NO donor 18¥ ¥ or SNAP ¤i.e., a rapid-release NO donor 12¥ ¥ at the concentration of 1 mM, Na ¦ -dependent taurine uptake was studied ¤Fig. 3¥. Consistent with the result of Smith et al.,
10¥ the taurine uptake was significantly reduced when pretreated with SN ¤52.8 + 3.8% of control taurine uptake, pg0.01, Fig. 3¥ while the taurine uptake was unaffected when pretreated with SNAP ¤i.e., 109.9 + 12.4% of control taurine uptake, Fig. 3¥ . Using a specific analytical assay for NO, 22, 23¥ it was previously noted that the rate of spontaneous generation of NO from SNAP 12¥ was approximately 500-fold faster than that from SN. 13¥ Since the exposure of RBBMV to NO generated from SNAP would have been significantly higher than that from SN, NO exposure alone is not likely to explain the functional reduction observed after SN. A number of studies indicate that peroxynitrite, a nitrogen oxide that is formed by the reaction between NO and superoxide, is known to inactivate the function of a number of proteins.
24,25¥ If the formation of peroxynitrite is involved in the functional impairment of the Na ¦ -dependent taurine uptake system, the presence of superoxide is likely to be crucial for the reduction in the activity. Therefore, SOD, a scavenger of superoxide, was tested to see if the functional impairment by SN pretreatment could be reversed. Interestingly, Na ¦ -dependent taurine uptake in RBBMV pretreated with SN and SOD ¤viz, 500 unit/ml, as a protein concentration 167 µg/ml¥, was not statistically different from the control ¤i.e., 89.4% of the control value¥ uptake ¤Fig. 3¥, indicating that the addition of SOD reversed the functional impairment caused by the pretreatment of SN. Furthermore, since the incubation that contained SOD alone did not lead to a reduction in the activity ¤i.e., the uptake value of 4.53 + 0.60 vs. 4.34 + 0.43 pmol/mg protein/20 s for SOD alone and control, respectively¥, both superoxide and NO appear necessary for the functional impairment of the taurine uptake system. However, since the addition of SOD may lower the concentration of NO generated from SN by the formation of S-nitrosothiols of the protein, 26¥ an experiment was conducted to determine whether an addition of bovine serum albumin as nonspecific protein can also reverse the functional impairment caused by SN. As expected, the pretreatment of RBBMV with 1 mM SN and 167 µg/ml bovine serum albumin did not reverse the functional impairment caused by SN ¤Fig. 3¥. Taken together, these observations indicate that SN, but not SNAP, functionally impairs Na ¦ -dependent taurine uptake activity and that the presence of superoxide and NO is required to cause the functional impairment of the taurine uptake system. Taurine uptake into TauT expressing oocytes in the presence of NO donors:
RT-PCR procedure readily amplified the TauT signal in a rat kidney sample and the nucleotide sequence of the cloned transporter was identical to the reported sequence ¤data not shown¥. Compared with the water-injected oocytes, the oocytes injected with TauT cRNA showed a 4.7 + 1.9 fold enhancement in taurine accumulation, indicating the cRNA is functionally expressed in the oocytes. Consistent with the results obtained in the RBBMV preparation ¤Fig. 3¥, taurine uptake activity was reduced in SN pre-treated oocytes ¤30.4 + 9.80% of control¥ while the activity was not affected in SNAP pre-treated oocytes ¤119 + 31.4% of control¥ ¤Fig. 4¥. In a control experiment, the treatment of oocytes with NO donors did not affect the mannitol accumulation ¤data not shown¥, indicating that the integrity of oocytes was maintained when treated with NO donor. In addition, SOD also reversed ¤110 + 34.0% of control taurine uptake¥ the functional impairment of taurine transporter caused by SN ¤Fig. 4¥ to the control level. Therefore, these observations indicate that taurine transporter is functionally impaired in the presence of SN, but not SNAP, and superoxide is required for the impairment.
Discussion
In the literature, there are numerous examples describing the alteration of functions of proteins 6,24¥ by nitrogen oxide forms. reported that SIN-1, a NO donor, and SOD reduced the uptake of taurine in a microvillous plasma membrane preparation. In addition, Lee and Kang 28¥ reported that SIN-1 treatment also resulted in a reduction of taurine uptake in TR-TBT cells, conditionally immortalized rat syncytiotrophoblast cells. Amongst nitrogen oxide forms that affect the function, NO and peroxynitrite have been widely recognized.
29®31¥ While NO itself is relatively reactive, its reaction with superoxide would lead to formation of peroxynitrite, a more chemically reactive species than NO. These nitrogen oxide forms may lead to a nitrosylation ¤i.e., primarily by NO 26¥ ¥ and/or nitration ¤i.e., primarily by peroxynitrite 32¥ ¥ of certain amino acid residues ¤e.g., cysteine residue for nitrosylation and tyrosine residue for nitration¥ in target proteins; such modifications have been positively correlated with the altered function of proteins.
26,32¥ Although specific molecular mechanism¤s¥ of functional impairment of taurine transporter by NO has not been elucidated in the present study, nitrosylation and/or nitration of amino acid residues of taurine transporter are the likely reasons for the observed impairment. Since certain pathological states are known to be associated with the formation of a high level of these nitrogen oxide forms ¤e.g., inflammation, ischemic/reperfusion injury and diabetes¥, the pathological level of nitrogen oxide forms may be related to the altered function of transporters and, ultimately, the pharmacokinetics of drugs and/or endogenous substances.
11¥ Despite the impact, however, it was not clear which nitrogen oxide forms were primarily responsible for the alteration, because NO, inorganic nitrite and peroxynitrite were likely to be present simultaneously in the experimental system. In this study, we demonstrated that a rapidly releasing NO donor, i.e., SNAP, did not lead to a functional impairment of taurine uptake in RBBMV, and the addition of superoxide dismutase reversed the impairment of taurine uptake caused by pre-treatment with SN in RBBMV. Consistent with the observations obtained in the RBBMV preparation, the profiles of functional impairment by the pretreatment with NO donors were similar in oocytes expressing rat TauT. Taken together, these observations indicate that peroxynitrite, rather than NO itself or inorganic nitrite, is responsible for the functional impairment of the rat taurine transporter by SN. To our knowledge, this is the first indication in the literature wherein a nitrogen oxide form requires activation with superoxide for the functional impairment of taurine transporter.
In the literature, it was indicated that pre-treatment with nitrogen oxide led to an inhibition of Na ¦ -K ¦ ATPase in mouse proximal tubule epithelial cells. 33¥ Since the maintenance of Na ¦ -gradient by Na ¦ -K ¦ ATPase is essential for the functions of Na ¦ -dependent transporters, the inhibition of Na ¦ -K ¦ ATP may be related to the functional impairment of taurine transporter after the pretreatment with SN. Previously, we have demonstrated the functional impairment of taurine transporter in the choroid plexus with ATPdepletion by which the ATPase is rendered inactive.
11¥
Furthermore, in a prior study, another Na ¦ -dependent transport system ¤viz, nucleoside transport system N1 34¥ ¥ was not affected by SN pretreatment.
11¥ These previous observations suggest the functional impairment of the taurine transporter is not directly related to the Na ¦ homeostasis. Furthermore, we studied the functional alteration in RBBMV in which the transport activity was examined under an exogenously applied Na ¦ -gradient. Taken together, the inhibition of Na ¦ -K ¦ ATPase by SN is not likely to be the primary mechanism for the reduction of taurine uptake.
In the report by Dulak et al., 35¥ byproducts ¤e.g., cyanide, ferrocyanide or ferricyanide ions¥ of SN affected the function of certain proteins. In this study, the effect of these byproducts was not studied. However, SN pretreatment in the presence of SOD did not lead to an impairment of the function of taurine uptake. Since the addition of SOD is not likely to affect the formation of these byproducts, the involvement of these byproducts in the alteration of the function on taurine uptake is not likely.
In summary, the functional activity of the taurine uptake system in rat RBBMV and oocytes expressing the rat taurine transporter was reduced by a slow-release NO donor, SN, and the impairment was reversed by the addition of SOD. A rapid-release NO donor, SNAP, did not affect the functional activity. These observations indicate that the functional impairment is likely to be mediated by an activation of NO with a superoxide anion rather than NO itself. Therefore, peroxynitrite, a highly reactive nitrogen oxide formed by the reaction between NO generated from SN and superoxide, may functionally impair taurine transporter. Since other secondary active transport systems were also functionally sensitive to SN pretreatment, 11¥ a similar mechanism of impairment may exist for other transport systems.
